McMillan Wayde D.
- SEC CIK
- 0001768648
No open-market purchases or sales filed in the past year.
Current role at each company
- SOLV Solventum CorpChief Financial Officeras of May 15, 2026
- HOLX Hologic IncDirectoras of Apr 9, 2026
- PODD Insulet CorpEVP, CFOas of Jul 6, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists McMillan Wayde D. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
PODD Insulet Corp
EVP, CFO5 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 6, 2023 (view filing) | Jul 3 | 3 days | McMillan Wayde D.EVP, CFO | SSale | −1.39K | $282.94 | −$392.7K | −6.1%21.5K after | 10b5-1 |
| Apr 4, 2023 (view filing) | Apr 3 | 1 day | McMillan Wayde D.EVP, CFO | SSale | −1.25K | $318.31 | −$399.5K | −5.2%22.9K after | 10b5-1 |
| Jan 4, 2023 (view filing) | Jan 3 | 1 day | McMillan Wayde D.EVP, CFO | SSale | −1.36K | $286.43 | −$389.3K | −6.4%20.0K after | |
| Apr 5, 2022 (view filing) | Apr 1 | 4 days | McMillan Wayde D.EVP, CFO | SSale | −1.46K | $275.60 | −$401.0K | −6.4%21.4K after | |
| Jan 4, 2022 (view filing) | Dec 31, 2021 | 4 days | McMillan Wayde D.EVP, CFO | SSale | −1.85K | $268.98 | −$499.0K | −8.5%20.1K after | 5 lots |